Marios K. Lazanas - Infectious Diseases

Author Information

Marios K. Lazanas is affiliated with the 3rd Internal Medicine Department-Infectious Diseases, Red Cross Hospital, located in Athens, Greece. He is a prominent researcher in the field of infectious diseases, focusing on HIV and its transmission dynamics, as well as the management of community-acquired pneumonia and COVID-19.

Research Contributions

Marios K. Lazanas has made significant contributions to understanding the transmission and management of infectious diseases, particularly HIV-1 and COVID-19. His research includes the investigation of HIV-1 clusters in Greece, the role of macrolides in treating pneumonia, and the dynamics of drug resistance among HIV-1 treatment-naïve individuals. He has published extensively on the epidemiology and public health implications of these diseases, providing valuable insights into their management and control.

Aliases

Marios K. Lazanas is also known by various aliases including Mario Lazanas, Marios Lazanas, M. K. Lazanas, M K Lazanas, and M. Lazanas. These variations appear in different publications and citations.

Publication and Citation Metrics

Metric	Value
Total Papers	42
Total Citations	1157
H-index	15

Publications:

Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in Europe

DOI: 10.3390/v14010101

Year: 2022

The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece

DOI: 10.1007/s40121-021-00471-1

Year: 2021

The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece.

DOI: 10.1007/s40121-021-00471-1

Year: 2021

Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in Greece

DOI: 10.1136/sextrans-2020-054509

Year: 2020

Moderate Hyperhomocysteinemia along with Increased Levels of Vitamin B12 in a 21-Year-Old Male with the Sanfilippo Syndrome: A Case Report

DOI: 10.1159/000512215

Year: 2020

A Nationwide Study about the Dispersal Patterns of the Predominant HIV-1 Subtypes A1 and B in Greece: Inference of the Molecular Transmission Clusters

DOI: 10.3390/v12101183

Year: 2020

Moderate hyperhomocysteinemia along with increased levels of B12 in a 21-y boy with the Sanfilippo syndrome in poor nutritional status.

DOI: 10.1016/j.clnesp.2018.01.014

Year: 2018

Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health

DOI: 10.3390/genes8110322

Year: 2017

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.

DOI: 10.1016/j.meegid.2017.07.003

Year: 2017

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

DOI: 10.7448/IAS.19.8.21487

Year: 2016

What are the Challenges in Infectious Disease Education?

How Does the Immune System Respond to Infections?

What Causes Respiratory Symptoms in Infectious Diseases?

Can Receptors Be Therapeutic Targets?

What Role Do Extreme Weather Events Play?

What Are the Challenges in Controlling Culex Mosquitoes?

What are the treatment options for Plasmodium falciparum malaria?

What Diseases are Transmitted by Aedes Albopictus?

How Do Antiparasitics Work?

What are Receptors?

Partnered Content Networks

Relevant Topics